Table 3.
Survey results: Determinants of prescribing therapeutic anticoagulation, n (%)
|
Item
|
Total (n = 93)
|
| Do you consider of ... the thrombosis as an important factor to prescribe therapeutic AC? (multiple answers were possible) | |
| Age (acute or chronic) | 78 (84) |
| Anatomical location (portal, splenic or superior mesenteric vein) | 42 (45) |
| Degree (total or partial) | 45 (48) |
| Extent (isolated thrombosis or thrombosis in several segments) | 49 (53) |
| Progression (over time) | 40 (43) |
| When do you prescribe therapeutic AC? In case of: | |
| (Sub)acute thrombosis | 84 (90) |
| Chronic thrombosis | 0 |
| Both | 9 (10) |
| Rank the anatomical location of the thrombosis from most likely to less likely to start therapeutic AC: | |
| Portal vein-splenic vein-superior mesenteric vein | 9 (10) |
| Portal vein-superior mesenteric vein-splenic vein | 61 (66) |
| Splenic vein-portal vein-superior mesenteric vein | 0 |
| Splenic vein-superior mesenteric vein-portal vein | 1 (1) |
| Superior mesenteric vein-portal vein-splenic vein | 19 (20) |
| Superior mesenteric vein-splenic vein-portal vein | 3 (3) |
| When do you prescribe therapeutic AC? In case of: | |
| Total thrombosis | 9 (10) |
| Partial thrombosis | 5 (5) |
| Both | 79 (85) |
| Do you consider the risk of ... as a major barrier to prescribe therapeutic AC? (multiple answers were possible) | |
| Bleeding in general | 52 (56) |
| Bleeding related to portal hypertension | 17 (18) |
| Bleeding related to pseudoaneurysm | 49 (53) |
| Other risk1 | 1 (1) |
| Does the need for invasive interventions for local complications of acute pancreatitis influence your decision regarding AC therapy? | |
| Yes | 48 (52) |
| No | 45 (48) |
1
In free text: CVA bleeding history.
AC: Anticoagulation; SVT: Splanchnic vein thrombosis.